The HPV vaccine, called Gardasil-9 — which has no live virus and is completely non-infectious — protects against the six types of HPV most likely to cause cancer, Eckert says. (These are strains 6, 11 ...
9h
Clinical Trials Arena on MSNFirst subject enrolled in MUSC Hollings’ Phase II/III trial of HNSCC treatmentHollings Cancer Center, US, has enrolled the first subject in the Phase II/III FORTIFI-NH01 trial of ficerafusp alfa to treat ...
The HPV (human papillomavirus) vaccine helps prevent cervical cancer by protecting against high-risk strains of the virus ...
Seegene Inc., a global leader in total solution for PCR molecular diagnostics, presented its high-precision Human ...
HPV is sexually transmitted, and once someone is infected there are no drugs that will rid them of the virus, experts said. The HPV vaccine, Gardasil 9, is recommended between ages 9 and 12 for ...
17d
News Medical on MSNNovel treatment approach shows promise for advanced HPV-negative head and neck cancerResearchers from the University of Chicago Medicine Comprehensive Cancer Center demonstrated the potential of a novel treatment approach including immunotherapy to treat advanced human papillomavirus ...
Most HPV infections cause no symptoms and clear up without treatment. Others develop into cancer, about 37,000 cases a year, according to the CDC. Women in their 20s are the group most likely to ...
A recent study published in JAMA Oncology presents promising new data on a treatment regimen beneficial to patients with a ...
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people ...
Denmark: A recent randomized clinical trial, VAXAK, has highlighted the potential benefits of human papillomavirus (HPV) vaccination in managing actinic keratosis (AK), a prevalent precancerous skin ...
12d
News-Medical.Net on MSNGaps in HPV cancer screening and prevention identified for people living with HIVA new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results